Search

everythinglearnresearchcommunity

for

Search:↓

NGAL may help maintain skin balance and is linked to skin disorders and cancers.

Certain inhibitors can potentially treat prostate cancer and other hormone-dependent conditions by controlling sex hormone levels in cells.

New compounds show promise for treating hair loss, enlarged prostate, and prostate cancer, with some being more effective and having different side effects than current treatments.

Hormone therapy for prostate cancer can increase heart risks, especially in men with heart conditions.

Losing 5-10% body weight can improve PCOS symptoms, letrozole is better than clomiphene for fertility, and managing weight and blood sugar is important to reduce pregnancy complications.

Low testosterone in men is a risk factor for a specific heart rhythm issue, and testosterone treatment may help prevent it.

DHT is a strong androgen that may pose less risk to the prostate compared to testosterone.

The SA-MS hydrogel is a promising material for improving wound healing and skin regeneration in diseases like diabetes and skin cancer.

5 alpha-reductase inhibitors like finasteride may lower prostate cancer risk and improve cancer screening.

As skin cells mature, vitamin D receptor levels decrease while retinoid X receptor α levels increase.

Cannabinoid receptor-1 signaling is essential for the survival and growth of human hair follicle stem cells.

Researchers found new potential treatments for conditions related to the androgen receptor, like male hormonal contraception, by testing thousands of compounds.

Finasteride helps treat prostate issues and may prevent prostate cancer in high-risk men.

ERβ has potential in treating prostate cancer and neurodegenerative diseases, but human studies are needed before clinical use.

New treatments for prostate cancer and BPH show promise, including novel compounds that target hormone synthesis and response.

Androgen deprivation therapy doesn't lower the risk of death from COVID-19 in prostate cancer patients.

The document concludes that managing PCOS involves treating symptoms, regulating periods, and reducing health risks, with specific medications for fertility and metabolic issues.

17β-estradiol lowers polyamine oxidase levels in breast cancer cells through estrogen receptor 2.

More compassion satisfaction reduces emotional exhaustion in caregivers.

New cancer treatments aim to reduce side effects and improve effectiveness.

HIV can cause skin disorders, which are often the first sign of infection, especially in people with darker skin.

Exemestane is effective and safe for treating certain breast cancers, with mild side effects, but needs more research on long-term effects.

Natural products may help treat Non-Small Cell Lung Cancer by causing cancer cell death through ferroptosis.

Testosterone therapy for transmasculine individuals is generally safe with medical supervision, improves mental health, and has mixed effects on physical health.

Androgen therapy can help with symptoms like low libido in women, but more research is needed to understand its long-term safety and effects on health.

Removing integrin α3β1 from hair stem cells lowers skin tumor growth by affecting CCN2 protein levels.

Skin problems are common after stem cell transplants, and early treatment by dermatologists can improve patient outcomes.

Dutasteride reduces hospitalization and prostate cancer risk compared to finasteride, potentially offsetting its higher cost.

Finasteride reduces prostate cancer risk by 30% without affecting Gleason scores.

Nanocarriers can improve the effectiveness of herbal medicines in treating colorectal cancer.